We’ve reviewed the documented benefits of curcurmin – the bioactive ingredient in turmeric – extensively on this blog, yet it seems that, with each new day, researchers from around the world are unearthing yet more immune-boosting applications for this natural compound. Past research has already indicated that curcumin supplements may prevent the spread of certain cancers including colon and prostate. Now, a new study from the General Hospital of Chinese PLA has indicated that this substance might help manage lung cancer as well.
The American Cancer Society estimates that 228,190 Americans are diagnosed with lung cancer each year, with smokers facing a much higher risk of developing the disease. The source notes that lung cancer has a higher mortality rate than any other form of the condition.
According to a study abstract released by Pubmed, the scientists projected that curcumin may be able to restrict the growth and metastasis of lung cancer cells based on evidence of such behavior with other forms of this disease.
“In the present study, we demonstrated that curcumin acted as a growth inhibitor for lung cancer cells. Our results found that curcumin inhibited cell proliferation [… and] we showed that curcumin induced the expression of forkhead box protein O1 (FOXO1) through activation of extracellular signal-regulated kinase 1/2 signaling,” the abstract states.
Though further research is necessary to support this finding, the researchers expressed the hope that the effects of curcumin may be simulated in future lung cancer treatments.
In addition to its potential ability to prevent the metastasis of cancerous cells, curcumin has also been shown to help mitigate rheumatoid arthritis pain, act as a memory enhancer and genrally improve the health of middle-aged individuals with no existing medical conditions. Click here to read more information about Nutrivene Longvida Curcumin.